Numab & Boehringer Ingelheim Hit Key Collaboration Milestone
Boehringer Ingelheim has advanced a Numab-derived multi-specific antibody for wet age-related macular degeneration into preclinical development, triggering a milestone...
Kamada Announces Surging $14M Canadian Supply Tender Growth
Kamada has secured a two-year extension from Canadian Blood Services to supply four specialty plasma-derived products—WinRho, HepaGam, CytoGam, and...
Camp4, GSK Form Strategic Collaboration for RNA Discoveries
CAMP4 Therapeutics has entered a research, collaboration, and license agreement with GSK to identify and develop antisense oligonucleotide drug...
Profound Therapeutics Strengthens Leadership With CTO, CHRO
Profound Therapeutics, a Flagship Pioneering company focused on discovering proteins within the expanded human proteome, has appointed Tom Chittenden...
Aptose Reschedules Shareholder Meeting for Hanmi Acquisition
Aptose Biosciences has postponed its special shareholder meeting originally set for January 16, 2026, to later in January, pending...
Zenas Biopharma Announces Inducement Grants Under Nasdaq Rule
Zenas BioPharma has granted non-qualified stock options for 300,000 shares to two newly hired employees as inducement awards under...
U.S. Cannabis Rescheduling Unlocks Growth for Medipharm Labs
The White House has issued an executive order directing expedited reclassification of cannabis from Schedule I to Schedule III...
Galapagos Announces TYK2 Results for Lupus & Dermatomyositis
Galapagos reported mixed topline readouts for its selective TYK2 inhibitor GLPG3667: a Phase 3–enabling dermatomyositis study met its primary...
Celularity Secures Financing to Support Strategic Vision
Celularity has entered binding term sheets for a $7 million senior secured term loan and up to $5 million...
Iovance Announces New Nasdaq-Approved Inducement Grants
Iovance Biotherapeutics granted inducement stock options covering 43,150 shares to four new non-executive employees, effective December 18, 2025, at...